Short Interest in Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) Declines By 36.7%

Posted by ABMN Staff on Mar 27th, 2026

Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT – Get Free Report) was the recipient of a significant decline in short interest in the month of March. As of March 13th, there was short interest totaling 12,913 shares, a decline of 36.7% from the February 26th total of 20,412 shares. Based on an average trading volume of 8,690 shares, the days-to-cover ratio is presently 1.5 days. Currently, 0.0% of the company’s shares are sold short.

Zhengye Biotechnology Price Performance

ZYBT opened at $0.85 on Friday. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.49 and a quick ratio of 1.10. The stock’s 50 day moving average price is $0.90 and its 200-day moving average price is $2.29. Zhengye Biotechnology has a 52-week low of $0.68 and a 52-week high of $14.30.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Zhengye Biotechnology in a report on Friday, January 9th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has an average rating of “Sell”.

Check Out Our Latest Stock Analysis on ZYBT

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the stock. Citadel Advisors LLC purchased a new stake in shares of Zhengye Biotechnology in the 3rd quarter worth about $31,000. Millennium Management LLC purchased a new position in shares of Zhengye Biotechnology during the third quarter valued at about $38,000. WINTON GROUP Ltd purchased a new position in shares of Zhengye Biotechnology during the third quarter valued at about $56,000. Geode Capital Management LLC bought a new position in Zhengye Biotechnology in the second quarter worth about $174,000. Finally, Invesco Ltd. bought a new position in Zhengye Biotechnology in the second quarter worth about $220,000.

Zhengye Biotechnology Company Profile

(Get Free Report)

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.